Related Experiment Video

Updated: Nov 9, 2025

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
09:30

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

Published on: February 21, 2015

18.7K

Induced Pluripotent Stem Cells (iPSCs) Technology: Potential Targets for Depression

Gabriela D Colpo1, Antonio L Teixeira2

  • 1Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Advances in Experimental Medicine and Biology
|April 9, 2021
PubMed

Insights

Major depressive disorder (MDD) presents complex challenges, with increasing treatment resistance. Induced pluripotent stem cells (iPSCs) offer a novel approach for understanding MDD pathophysiology and validating new therapeutic targets.

Area of Science:

  • Neuroscience and Psychiatry
  • Stem Cell Biology
  • Genetics and Genomics

Background:

  • Major depressive disorder (MDD) is a complex, heterogeneous psychiatric condition influenced by genetic and environmental interactions.
  • Current therapeutic options for MDD are insufficient, leading to a growing number of treatment-resistant cases.
  • Existing disease models fail to fully capture the intricate pathophysiology of MDD.

Purpose of the Study:

  • To explore the potential of induced pluripotent stem cells (iPSCs) for modeling MDD.
  • To identify novel pathways involved in MDD pathogenesis.
  • To validate new therapeutic targets for MDD treatment.

Main Methods:

  • Utilizing induced pluripotent stem cells (iPSCs) derived from patients with MDD.
  • Developing iPSC-based disease models to study cellular and molecular mechanisms of MDD.
  • Investigating genetic and environmental factors influencing iPSC differentiation and function.

Main Results:

  • iPSC-derived models show promise in recapitulating aspects of MDD pathophysiology.
  • This approach facilitates the identification of previously unrecognized pathways implicated in MDD.
  • Early findings suggest iPSCs can aid in the validation of potential therapeutic targets.

Conclusions:

  • Induced pluripotent stem cells (iPSCs) represent a powerful tool for advancing the understanding of MDD.
  • iPSC-based disease modeling is crucial for developing more effective treatments for treatment-resistant depression.
  • This technology holds significant potential for personalized medicine approaches in psychiatry.
Keywords:
Cell therapyDepressionDisease modelingDrug screeningiPSCs

More Related Videos

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.4K
Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring09:34

Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring

Published on: August 6, 2020

7.5K

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.4K